FDA Authorizes Pfizer COVID-19 Booster For Children Ages 12-15

The FDA quietly announced they’re expanding emergency use authorization of the Pfizer-BioNTech COVID-19 booster to children ages 12-15. Healthy children have over a 99.99% survival rate from COVID-19, so I wonder what type of delusional emergency the FDA thinks exists in our kids. Omicron is even milder than previous strains, but that’s beside the point. … Continue reading FDA Authorizes Pfizer COVID-19 Booster For Children Ages 12-15